In a significant move underscoring its commitment to healthcare innovation, Mumbai-based pharmaceutical titan Lupin Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for their Oxcarbazepine Extended-Release (ER) tablets. This milestone is not only a testament to Lupin’s relentless drive in the search for better treatment options for seizure disorders […]